|
|
 |
| |
|
Home > Drug Companies > Fujisawa Healthcare, Inc.
| |
Pharmaceutical Courses |
|
Pharmacy Technician
Allied College
Arnold, MO |
Pharmacy Technician
Allied College
Saint Ann, MO |
Pharmacy Technician
Cambridge College
Portland, OR |
Pharmacy Technician
Cambridge College
Seattle, WA |
Pharmacy Technician
High Tech Institute
Irving, TX |
Pharmacy Technician
High Tech Institute
Atlanta, GA |
Pharmacy Technician
High Tech Institute
Memphis, TN |
Pharmacy Technician
High Tech Institute
Minneapolis, MN |
Pharmacy Technician
High Tech Institute
Orlando, FL |
Pharmacy Technician
High Tech Institute
Sacramento, CA |
Pharmacy Technician
The Bryman School
Phoenix, AZ |
|
Fujisawa Healthcare, Inc.
On April 1, 2005 Fujisawa Pharmaceutical Co., Ltd. and Yamanouchi Pharmaceutical Co., Ltd. merged to form Astellas Pharma Inc. Created from a partnership of two respected, leading global companies, Astellas is built on a strategic platform focused in select therapeutic areas: Cardiology, Dermatology, Immunology, Infectious Disease and Urology. Within each therapeutic area, Astellas focuses on unsurpassed science and building networks of trust among physicians, patients and partners.
Their position as a leader in the field of transplantation is a proud accomplishment. They have dedicated an enormous amount of energy to understanding the idiosyncrasies of immunology as it relates to transplant medicine.
Ongoing clinical research and new product development are invaluable for improving their knowledge base and strengthening their experience. The transference and sharing of vast amounts of scientific knowledge is an ongoing priority for Astellas. They have a commitment to immunology that goes well beyond obligation. It is their passion and their priority.
Community outreach continues to play a pivotal role in securing a successful future for transplantation. Honoring a long-standing commitment, Astellas will continue to serve as a compelling voice to the community through support and advocacy. Their history of collaborating with investigators around the world provides ideal environments to study compounds that have the potential for significant breakthroughs.
Their commitment to the field of infectious diseases is an active one. They're expanding the knowledge base of this therapeutic area and empowering physicians to make evidence-based clinical decisions. Their proud history of collaborating with investigators around the world provides ideal environments to study compounds that have the potential for significant breakthroughs and allows them to generate and publish key information on their advances.
Astellas recognizes that in collaborations their partners' needs are just as important as their own. Astellas Alliance Management in the U.S. serves as a bridge between companies, taking professional alignment and turning it into productive working relationships. With an emphasis on communication and coordination, Alliance Management is involved in every aspect of Astellas' collaborations in the U.S. from initial contract negotiation onwards. This helps to target their collaborative efforts and makes sure that all parties are satisfied.
Back to Drug Companies
|
|
|
|
|
|
|
|